Friday, July 10, 2026

pharma · Allergy · Allergic rhinoconjunctivitis

A. MENARINI MANUFACTURING

A. Menarini Industrie is a pharma organization headquartered in FIRENZE, IT. Primary therapeutic focus areas include Allergy, Allergic rhinoconjunctivitis. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), a

Florence, IT HQ
122 Employees
EMA registrant Type
Company details
Status
Public
HQ
Florence, IT
Employees
122
Programs
2
Drugs
6
Patents
5
Clinical program

Bilaxten Flas 10 mg comprimidos bucodispersables

Approved · small molecule · Allergic rhinoconjunctivitis

Bilaxten Flas 10 mg comprimidos bucodispersables for Allergic rhinoconjunctivitis is a Approved program (small_molecule) at A. Menarini Industrie Farmaceutiche Riunite s.r.l. with 1 ClinicalTrials.gov record(s).

Internal code BILA-4124/PED

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
A. Menarini Industrie Farmaceutiche Riunite s.r.l.
Phase
Approved
Modality
small_molecule
Indication
Allergic rhinoconjunctivitis
Status
active
Trials
1

Clinical trials